BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18376125)

  • 1. Impact of telemedical care and monitoring on morbidity in mild to moderate chronic heart failure.
    Morguet AJ; Kühnelt P; Kallel A; Jaster M; Schultheiss HP
    Cardiology; 2008; 111(2):134-9. PubMed ID: 18376125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results after a telephone intervention in chronic heart failure: DIAL (Randomized Trial of Phone Intervention in Chronic Heart Failure) follow-up.
    Ferrante D; Varini S; Macchia A; Soifer S; Badra R; Nul D; Grancelli H; Doval H;
    J Am Coll Cardiol; 2010 Jul; 56(5):372-8. PubMed ID: 20650358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of telemedicine by heart disease patients following hospitalization.
    Morguet AJ; Kühnelt P; Kallel A; Rauch U; Schultheiss HP
    J Telemed Telecare; 2008; 14(4):178-81. PubMed ID: 18534950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemia and prognosis of patients with chronic heart failure--subanalysis of the Long-term Prospective Randomized Controlled Study Using Repetitive Education at Six-Month Intervals and Monitoring for Adherence in Heart Failure Outpatients (REMADHE) trial.
    Issa VS; Amaral AF; Cruz FD; Ayub-Ferreira SM; Guimarães GV; Chizzola PR; Souza GE; Bocchi EA
    Am Heart J; 2010 Jan; 159(1):90-7. PubMed ID: 20102872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design.
    Koehler F; Winkler S; Schieber M; Sechtem U; Stangl K; Böhm M; Boll H; Kim SS; Koehler K; Lücke S; Honold M; Heinze P; Schweizer T; Braecklein M; Kirwan BA; Gelbrich G; Anker SD;
    Eur J Heart Fail; 2010 Dec; 12(12):1354-62. PubMed ID: 21098580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary outpatient congestive heart failure clinic: impact on hospital admissions and emergency room visits.
    Martineau P; Frenette M; Blais L; Sauvé C
    Can J Cardiol; 2004 Oct; 20(12):1205-11. PubMed ID: 15494772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study.
    Koehler F; Winkler S; Schieber M; Sechtem U; Stangl K; Böhm M; Boll H; Baumann G; Honold M; Koehler K; Gelbrich G; Kirwan BA; Anker SD;
    Circulation; 2011 May; 123(17):1873-80. PubMed ID: 21444883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perception and provider assessment of severity of heart failure as predictors of hospitalization.
    Subramanian U; Weiner M; Gradus-Pizlo I; Wu J; Tu W; Murray MD
    Heart Lung; 2005; 34(2):89-98. PubMed ID: 15761453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with chronic heart failure encountered in daily clinical practice are different from the "typical" patient enrolled in therapeutic trials.
    Badano LP; Di Lenarda A; Bellotti P; Albanese MC; Sinagra G; Fioretti PM
    Ital Heart J; 2003 Feb; 4(2):84-91. PubMed ID: 12762270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New multidisciplinary heart failure care program (six-month preliminary observation)].
    Wierzchowiecki M; Poprawski K; Nowicka A; Kandziora M; Piatkowska A; Jankowiak M; Michałowicz B; Stawski W; Kaszuba D
    Pol Merkur Lekarski; 2006 Dec; 21(126):511-5. PubMed ID: 17405287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity and focus of heart failure disease management after hospital discharge.
    Shah MR; Flavell CM; Weintraub JR; Young MA; Hasselblad V; Fang JC; Nohria A; Lewis EF; Givertz MM; Mudge G; Stevenson LW
    Am Heart J; 2005 Apr; 149(4):715-21. PubMed ID: 15990758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of telemetric management on overall treatment costs and mortality rate among patients with chronic heart failure].
    Kielblock B; Frye Ch; Kottmair S; Hudler T; Siegmund-Schultze E; Middeke M
    Dtsch Med Wochenschr; 2007 Mar; 132(9):417-22. PubMed ID: 17315117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (TElemonitoring in the MAnagement of Heart Failure) study.
    Dendale P; De Keulenaer G; Troisfontaines P; Weytjens C; Mullens W; Elegeert I; Ector B; Houbrechts M; Willekens K; Hansen D
    Eur J Heart Fail; 2012 Mar; 14(3):333-40. PubMed ID: 22045925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telecardiology for patients with chronic heart failure: the 'SHL' experience in Israel.
    Roth A; Kajiloti I; Elkayam I; Sander J; Kehati M; Golovner M
    Int J Cardiol; 2004 Oct; 97(1):49-55. PubMed ID: 15336806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of implantable cardioverter defibrillators on survival and recurrent hospitalization in advanced heart failure.
    Nazarian S; Maisel WH; Miles JS; Tsang S; Stevenson LW; Stevenson WG
    Am Heart J; 2005 Nov; 150(5):955-60. PubMed ID: 16290971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight monitoring in patients with severe heart failure (WISH). A randomized controlled trial.
    Lyngå P; Persson H; Hägg-Martinell A; Hägglund E; Hagerman I; Langius-Eklöf A; Rosenqvist M
    Eur J Heart Fail; 2012 Apr; 14(4):438-44. PubMed ID: 22371525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population.
    Sacher F; Probst V; Bessouet M; Wright M; Maluski A; Abbey S; Bordachar P; Deplagne A; Ploux S; Lande G; Jaïs P; Hocini M; Haïssaguerre M; Le Marec H; Clémenty J
    Europace; 2009 Apr; 11(4):489-94. PubMed ID: 19218576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
    Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
    Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.